Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Nuclear Science and Technology (3)
- Biology and Environment (9)
- Clean Energy (15)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (10)
- Fusion Energy (3)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (39)
- Materials Characterization (1)
- Materials for Computing (5)
- Materials Under Extremes (1)
- National Security (6)
- Neutron Science (17)
- Sensors and Controls (1)
- Supercomputing (13)
News Topics
- (-) Biomedical (1)
- (-) Fusion (1)
- (-) Materials Science (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (2)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Isotopes (2)
- Neutron Science (1)
- Nuclear Energy (7)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.